Literature DB >> 17885295

Prevalence and factors associated with dry skin in HIV infection: the FRAM study.

Daniel Lee1, Constance A Benson, Cora E Lewis, Carl Grunfeld, Rebecca Scherzer.   

Abstract

OBJECTIVE: Complaints of dry skin in HIV-infected individuals were reported after the advent of HAART. The objective of the study was to evaluate the prevalence of dry skin and associated factors in HIV-infected and control subjects.
DESIGN: Cross-sectional.
METHODS: A total of 1026 HIV-infected subjects and 274 controls [from the Coronary Artery Risk Development in Young Adults (CARDIA) study, a population-based study of cardiovascular risk assessment] in the Study of Fat Redistribution and Metabolic Change in HIV infection (FRAM) had skin assessed by self-report and examination. Multivariable logistic regression identified factors associated with dry skin.
RESULTS: Self-reported dry skin was more prevalent in HIV-infected subjects than controls. In multivariable analysis, HIV infection was associated with self-reported dry skin. In HIV-infected men, current indinavir use, CD4 cell count less than 200 cells/microl and recent opportunistic infections were associated with dry skin. Indinavir use had an elevated risk in men with CD4 cell counts of 200 cells/microl or greater but not with CD4 cell counts less than 200 cells/microl. In HIV-infected women, a CD4 cell count less than 200 cells/microl was associated with dry skin; indinavir use did not reach statistical significance but, as in men, indinavir use had an elevated risk in those with higher CD4 cell counts than in those with CD4 cell counts less than cells/microl.
CONCLUSION: Dry skin is more common in HIV-infected individuals than controls. In HIV-infected individuals, low CD4 cell counts and indinavir use in those with higher CD4 cell counts are associated with dry skin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17885295      PMCID: PMC3166536          DOI: 10.1097/QAD.0b013e3282eea51a

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  25 in total

1.  Depletion of cutaneous peptidergic innervation in HIV-associated xerosis.

Authors:  A Rowe; E Mallon; P Rosenberger; M Barrett; J Walsh; C B Bunker
Journal:  J Invest Dermatol       Date:  1999-03       Impact factor: 8.551

2.  The changing spectrum of the cutaneous manifestations of HIV disease.

Authors:  M Costner; C J Cockerell
Journal:  Arch Dermatol       Date:  1998-10

3.  Paronychia and pyogenic granuloma of the great toes in patients treated with indinavir.

Authors:  F Bouscarat; C Bouchard; D Bouhour
Journal:  N Engl J Med       Date:  1998-06-11       Impact factor: 91.245

Review 4.  Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

Authors:  A Carr; K Samaras; D J Chisholm; D A Cooper
Journal:  Lancet       Date:  1998-06-20       Impact factor: 79.321

5.  Fat distribution in men with HIV infection.

Authors:  Peter Bacchetti; Barbara Gripshover; Carl Grunfeld; Steven Heymsfield; Heather McCreath; Dennis Osmond; Michael Saag; Rebecca Scherzer; Michael Shlipak; Phyllis Tien
Journal:  J Acquir Immune Defic Syndr       Date:  2005-10-01       Impact factor: 3.731

6.  The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression.

Authors:  S Uthayakumar; R Nandwani; T Drinkwater; A T Nayagam; C R Darley
Journal:  Br J Dermatol       Date:  1997-10       Impact factor: 9.302

7.  Prevalence of cutaneous disorders in a population of HIV-infected patients. Southwestern France, 1996. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

Authors:  R Spira; M Mignard; M S Doutre; P Morlat; F Dabis
Journal:  Arch Dermatol       Date:  1998-10

8.  Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex.

Authors:  D S Goodman; E D Teplitz; A Wishner; R S Klein; P G Burk; E Hershenbaum
Journal:  J Am Acad Dermatol       Date:  1987-08       Impact factor: 11.527

9.  Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS).

Authors:  M H Kaplan; N Sadick; N S McNutt; M Meltzer; M G Sarngadharan; S Pahwa
Journal:  J Am Acad Dermatol       Date:  1987-03       Impact factor: 11.527

10.  Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse.

Authors:  M A Muñoz-Pérez; A Rodriguez-Pichardo; F Camacho; M A Colmenero
Journal:  Br J Dermatol       Date:  1998-07       Impact factor: 9.302

View more
  2 in total

1.  Epidermal barrier dysfunction in non-atopic HIV: evidence for an "inside-to-outside" pathogenesis.

Authors:  Roshan Gunathilake; Matthias Schmuth; Tiffany C Scharschmidt; Robert Gruber; Daniela Grabher; Kieron S Leslie; Toby A Maurer; Theodora M Mauro; Peter M Elias
Journal:  J Invest Dermatol       Date:  2009-11-19       Impact factor: 8.551

Review 2.  [Mucocutaneous infections in immunosuppression].

Authors:  P H Itin; M Battegay
Journal:  Internist (Berl)       Date:  2009-02       Impact factor: 0.743

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.